Tissue-Agnostic Precision Medicine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Tissue-Agnostic Precision Medicine
May 25, 2024, 11:59 |
Blog
Vivek Subbiah: ASCO 24 time to learn the latest and greatest in Tissue Agnostic Precision Medicine
Vivek Subbiah shared on X: “It's ASCO 24 time Mark your calendars to learn the latest…
Apr 8, 2024, 03:45 |
Drugs
Vivek Subbiah: First ADC tissue agnostic drug approved!
Quoting Vivek Subbiah's post on LinkedIn: "Just in time for American Association for Cancer Research…
Jan 25, 2024, 08:51 |
Insight
Vivek Subbiah: Tissue Agnostic Precision Medicine in Primary brain tumors like glioblastoma?
Vivek Subbiah shared on LinkedIn: "Hot off the press. What is the impact of Tissue Agnostic…
Dec 4, 2023, 15:54 |
Blog
Vivek Subbiah: Tissue-agnostic precision medicine takes the spotlight!
Vivek Subbiah shared a post on his LinkedIn page: "Hot off the press- Friday Motivation!…
Nov 26, 2023, 15:32 |
Blog
Vivek Subbiah: This review delves into the evolution of basket trials in cancer drug development
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on LinkedIn:…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube